Another Reason to Study Your Biotech ETF’s Holdings

Active followers of the biotechnology industry likely still remember the day in January when shares of Intercept Pharmaceuticals (NasdaqGM: ICPT) nearly quadrupled in a single trading session after trials for the company’s liver disease treatment proved successful. Investors in biotech exchange...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.